Table 1 Patient clinical characteristics, medication use and laboratory parameters, overall and by the presence of abdominal calcification

Age (years), mean (sd)

47.3 (13.0)

35.8 (8.5)

52.3 (9.6)

0.001

Male: n (%)

39 (61 %)

18 (75 %)

21 (52 %)

0.07

Dialysis Modality:

0.95

Haemodialysis

39 (60.9 %)

15 (62.5 %)

24 (60 %)

Peritoneal dialysis

23 (35.9 %)

8 (33.3 %)

15 (37.5 %)

None (Pre-emptive)

2 (3.2 %)

1 (4.2 %)

1 (2.5 %)

Duration of dialysis (years),

2.3

1.6

3.0

0.03

Median (IQR)

(1.6, 3.3)

(0.8, 2.0)

(1.7, 3.8)

Duration of Transplant (years),

3.7

3.2

4.1

0.40

Median (IQR)

(0.9, 8.1)

(0.9, 8.8)

(0.9, 7.1)

Mean Arterial BP (mm Hg), Mean (sd)

102.7 (9.7)

100.0 (8.8)

104.7 (8.9)

0.01

Body Mass Index (Kg/m²)

25.6

23.7

26.0

0.16

Median (IQR)

(22.8, 30.0)

(22.1, 29.3)

(23.4, 30.1)

Diabetes: N (%)

10 (15.6 %)

3 (12.5 %)

7 (17.5 %)

0.60

Ever Smoked: N (%)

28 (43.8 %)

8 (33.3 %)

20 (50 %)

0.19

Prior parathyroidectomy N (%)

8 (12.5 %)

3 (12.5 %)

5 (12.5 %)

1.0

Past History CV event: N (%)

6

0

6

0.05

Tacrolimus: N (%)

56 (87.5 %)

21 (87.5 %)

35 (87.5 %)

1.0

Mycophenolate mofetil: N (%)

52 (81.2 %)

17 (70.8 %)

35 (87.5 %)

0.10

Corticosteroid, N (%)

28 (43.8 %)

10 (41.7 %)

18 (45 %)

0.80

Vitamin D: N (%)

5

1

4

0.64

eGFR (ml/min per1.73 m²) mean (sd)

54.1 (17.6)

57.8 (14.8)

48.3 (14.9)

0.002

iPTH (ng/ml), median (IQR)

91.5 (73,108)

106.5 (83.5, 75.0)

86.5 (57,128)

0.85

Alkaline Phosphatase

106.2 (50.7)

106.5 (38.3)

106.0 (57.3)

0.97

Serum calcium (mmol/L), mean (sd)

2.57 (0.17)

2.52 (0.16)

2.63 (0.17)

0.06

Serum Phosphate (mmol/L), mean (sd)

1.01 (0.22)

1.00 (0.24)

1.02 (0.21)

0.70

Serum Cholesterol (mmol/L), Mean (sd)

4.7 (1.1)

4.2 (0.9)

5.0 (1.0)

0.006

Serum LDL Cholesterol (mmol/L), mean (sd)

2.65 (0.91)

2.34 (0.78)

2.82 (0.94)

0.06

Serum HDL Cholesterol (mmol/L), mean (sd)

1.35 (0.40)

1.28 (0.35)

1.39 (0.42)

0.36